PureHealth Delivers Triple Digit Net Profit Growth to USD 134 Million with EBITDA Soaring to USD 294 Million

PureHealth Bahrain Iran Iraq Jordan Kuwait Lebanon Oman Palestine Qatar Saudi Arabia Syria Yemen Algeria Egypt Libya Morocco Sudan Tunisia Western Sahara England United States of America Middle East United Arab Emirates United Kingdom

PureHealth achieved a robust 52% year-on-year revenue increase to USD 1.7 billion in Q1 2024, driven by ongoing organic growth and successfully completed strategic acquisitions.EBITDA surged by 127% year-on-year to around USD 294 million, with operational efficiencies improving across all key segments. The EBITDA margin rose to around 18% in Q1 2024 from 12% in Q1 2023.PureHealth has a Net Cash balance of c. USD 1.2 Billion (excluding lease liabilities) on 31 March 2024, resulting in a Net Cash to EBITDA (LTM 31 March 2024) ratio of (1.45x). View original content:https://www.prnewswire.co.uk/news-releases/purehealth-delivers-triple-digit-net-profit-growth-to-usd-134-million-with-ebitda-soaring-to-usd-294-million-302134384.html